| News
Roche launches new coronavirus antibody test
18.09.2020
Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development of vaccines. In addition, a drug from the Basel-based pharma giant has proven to be effective against coronavirus-associated pneumonia.

Roche Headquarter in Basel
Roche is launching a new antibody test that will identify people to have already been infected with coronavirus whose bodies have now developed antibodies against the virus. The test should help in developing vaccines against SARS-CoV-2. In specific terms, the test focuses on antibodies against the spike protein of SARS-CoV-2. The majority of vaccine candidates are aimed at inducing an antibody reaction against the spike protein.
The test will initially be launched in countries that accept that CE mark of the European Union (EU), as detailed in a press release. Roche has, however, also applied for Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA). The new test is actually the Basel-based pharma group’s twelfth coronavirus test in its testing portfolio.
In addition to launching a new test, Roche has also announced a success in relation to its drug Actemra/RoActemra. This has proven to be successful in treating patients suffering from pneumonia linked to a coronavirus infection. Patients that were administered Actemra/RoActemra in addition to the standard treatment, were 44 percent less likely to require ventilation or die as the disease progressed in comparison with those patients to receive only standard treatment and a placebo.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
MTIP using new fund to invest in innovative companies
The Basel-based firm MTIP AG specializes in investments in HealthTech companies. A total of 130 million euros has already been...
Read MoreBasel Area records successful 2020
Basel Area Business & Innovation was able to newly settle a total of 27 companies in the Basel Area in...
Read MoreBetterDoc opts for Basel
The online medical service BetterDoc has selected Basel as its Swiss location. Together with the health insurance firm Assura, it...
Read MoreKybora settles its European headquarters in Basel
The American consultancy Kybora, which operates within the life sciences industry, has established its European headquarters in Basel. Kybora GmbH...
Read MoreEscientia establishes subsidiary in the Basel Area
The U.S. company Escientia Life Sciences Group has established a subsidiary in the canton of Basel-Landschaft. Escientia Switzerland will offer...
Read MoreBasel presents itself as center of innovation at the House of Switzerland in Tokyo
Around a dozen innovative companies and institutions from the Basel Area are planning a joint marketing presence in Tokyo under...
Read More